AbbVie Inc. (ABBV) 41st Annual J.P. Morgan Healthcare Conference - (Transcript)Seeking Alpha • 01/11/23
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology TargetsPRNewsWire • 01/10/23
AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer DealInvestors Business Daily • 01/06/23
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology TargetsPRNewsWire • 01/06/23
Johnson & Johnson Vs. AbbVie: The Better Dividend Aristocrat Buy Might Shock YouSeeking Alpha • 01/06/23
My Dividend Stock Portfolio: New December Record - 96 Holdings With 24 Buys, 6 SalesSeeking Alpha • 01/05/23
These 2 Cheap Dividend Stocks Yield More Than 3% -- and They Beat the Market Last YearThe Motley Fool • 01/04/23
Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical TrialBusiness Wire • 01/04/23